Netherlands· NL-3367ddc8c830
Rekovelle 36 microgram, oplossing voor injectie
A follitropin delta product containing follitropine delta, registered in Netherlands by Ferring Pharmaceuticals A/S. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Follitropin delta is registered in 12 of 19 countries.
Countries holding a registration under ATC G03GA10 (follitropin delta), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Follitropin delta · ATC G03GA10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FOLLITROPINE DELTA
- Manufacturer
- Ferring Pharmaceuticals A/S
- Country
- Netherlands (NL)
- ATC code
- G03GA10
- ATC class
- Follitropin delta
- Defined daily dose
- 12 mcg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/16/1150
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Follitropin delta in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRekovelle 12 µg/0.36 mlFerring Pharmaceuticals
- SpainREKOVELLE 12 MICROGRAMOS/0,36 ML SOLUCIÓN INYECTABLEFerring Pharmaceuticals A/S
- United KingdomRekovelle 12micrograms/0.36ml solution for injection cartridgesFerring Pharmaceuticals Ltd
- SwedenREKOVELLE 12 mikrogram/0,36 mL Injektionsvätska, lösningFerring Pharmaceuticals A/S
- NorwayRekovelleFerring Pharmaceuticals A/S
- FinlandREKOVELLEFerring Pharmaceuticals A/S
- FranceREKOVELLE 12 microgrammes/0,36 mL, solution injectable en stylo prérempliFERRING PHARMACEUTICALS (DANEMARK)
- PolandRekovelleFerring Pharmaceuticals A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rekovelle
- Liechtenstein · Rekovelle
- Norway · Rekovelle
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edf55bf6-8184-4e77-8377-6c1bc28f23d4 GET /v1/drugs/edf55bf6-8184-4e77-8377-6c1bc28f23d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/rekovelle-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Follitropin delta",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp118198",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
"FENOL",
"FOSFORZUUR (E 338)",
"METHIONINE, (L-)",
"NATRIUMHYDROXIDE (E 524)",
"NATRIUMSULFAAT 10-WATER (E 514 (I))",
"POLYSORBAAT 20 (E 432)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"FOLLITROPINE DELTA"
],
"leaflet_url": null,
"authorised_at": "2016/12/12",
"procedure_number": "EMEA/H/C/003994",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/16/1150",
"additional_monitoring": "N"
}See everything about follitropin delta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.